newsfilter
← Latest News
Business Wire·

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revance Therapeutics, Inc. (NASDAQ:RVNC) today announced new hire grants totaling an aggregate of 104,800 inducement restricted stock units ("RSUs") to 31 employees. The RSUs vest over four years, with 25% of the